BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1380040)

  • 1. A recombinant malaria protein that can induce Th1 and CD8+ T cell responses without antibody formation.
    Süss G; Pink JR
    J Immunol; 1992 Aug; 149(4):1334-9. PubMed ID: 1380040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on 27-kDa sexual stage antigen of Plasmodium falciparum.
    Koski GK; Ploton IN; Viscidi R; Kumar N
    Pept Res; 1996; 9(3):127-35. PubMed ID: 8875592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic Plasmodium falciparum circumsporozoite peptides elicit heterogenous L3T4+ T cell proliferative responses in H-2b mice.
    Togna AR; Del Giudice G; Verdini AS; Bonelli F; Pessi A; Engers HD; Corradin G
    J Immunol; 1986 Nov; 137(9):2956-60. PubMed ID: 2428881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the T cell response to two allelic forms of a malarial vaccine candidate protein.
    Rzepczyk CM; Csurhes PA; Saul AJ; Jones GL; Dyer S; Chee D; Goss N; Irving DO
    J Immunol; 1992 Feb; 148(4):1197-204. PubMed ID: 1371134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA.
    Troye-Blomberg M; Olerup O; Perlmann H; Larsson A; Elghazali G; Fogdell A; Jepsen A; Lepers JP; Pandey JP; Grunewald J
    Behring Inst Mitt; 1994 Dec; (95):97-105. PubMed ID: 7755513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected problems of malaria blood stage immunity.
    Perlmann P; Perlmann H; Berzins K; Troye-Blomberg M
    Tokai J Exp Clin Med; 1998 Apr; 23(2):55-62. PubMed ID: 10021776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice.
    Shimizu J; Kanagawa O; Unanue ER
    J Immunol; 1993 Aug; 151(3):1723-30. PubMed ID: 8101546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha beta T cell receptor-positive intraepithelial lymphocytes with CD4+, CD8- and CD4+, CD8+ phenotypes from orally immunized mice provide Th2-like function for B cell responses.
    Fujihashi K; Yamamoto M; McGhee JR; Kiyono H
    J Immunol; 1993 Dec; 151(12):6681-91. PubMed ID: 7903096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
    Scott P
    J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific suppressor factors of noncytotoxic CD8+ suppressor T cells downregulate antibody responses also to unrelated antigens when the latter are presented as covalently linked adducts with the specific antigen.
    Bitoh S; Takata M; Maiti PK; Holford-Strevens V; Kierek-Jaszczuk D; Sehon AH
    Cell Immunol; 1993 Aug; 150(1):168-93. PubMed ID: 8343965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
    Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS
    J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
    Bergmann ES; Ballou RW; Krzych U
    Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunologic significance of variation within malaria circumsporozoite protein sequences.
    De La Cruz VF; Maloy WL; Miller LH; Good MF; McCutchan TF
    J Immunol; 1989 May; 142(10):3568-75. PubMed ID: 2523929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.
    Schirmbeck R; Melber K; Kuhröber A; Janowicz ZA; Reimann J
    J Immunol; 1994 Feb; 152(3):1110-9. PubMed ID: 8301120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.
    Chougnet C; Troye-Blomberg M; Deloron P; Kabilan L; Lepers JP; Savel J; Perlmann P
    J Immunol; 1991 Oct; 147(7):2295-301. PubMed ID: 1717554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells.
    Good MF; Branigan J; Smith G; Houghten RA
    Pept Res; 1990; 3(3):110-5. PubMed ID: 1724615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.
    Li Y; McGowan P; Hellström I; Hellström KE; Chen L
    J Immunol; 1994 Jul; 153(1):421-8. PubMed ID: 7515929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.